Health Canada recently approved lecanemab (brand name Leqembi®) to treat people with mild cognitive impairment or mild ...

First central lab in EU to perform this blood-based assay under IVDR/LDT regulations, supporting inclusion and exclusion criteria in Alzheimer’s clinical trials Achieving IVDR validation for the ...

Reduced amyloid burden after treatment with the antiamyloid donanemab (Kisunla, Eli Lilly) correlated strongly with slower cognitive and functional decline in adults with early symptomatic Alzheimer’s ...

TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta plaques associated with Alzheimer's disease, performed so well in a phase Ib/IIa ...

The U.S. Food and Drug Administration (FDA) stated on Thursday that it is requiring an additional MRI scan for Alzheimer's patients receiving Leqembi (lecanemab), citing safety concerns over a rare ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook It’s important to note that you can mix and match any gun you want with different classes in ...

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. A new study finds that the element lithium plays a crucial role in healthy brain function and ...

A recent study led by a team of researchers at The Johns Hopkins University School of Medicine examining aging mice has provided what is believed to be the first evidence that amyloid beta ...